Nothing Special   »   [go: up one dir, main page]

SI2116227T1 - Oftalmični sestavki, ki vsebujejeo sinergistično kombinacijo dveh polimerov - Google Patents

Oftalmični sestavki, ki vsebujejeo sinergistično kombinacijo dveh polimerov

Info

Publication number
SI2116227T1
SI2116227T1 SI200432047T SI200432047T SI2116227T1 SI 2116227 T1 SI2116227 T1 SI 2116227T1 SI 200432047 T SI200432047 T SI 200432047T SI 200432047 T SI200432047 T SI 200432047T SI 2116227 T1 SI2116227 T1 SI 2116227T1
Authority
SI
Slovenia
Prior art keywords
polymers
compositions containing
synergistic combination
ophthalmic compositions
ophthalmic
Prior art date
Application number
SI200432047T
Other languages
English (en)
Inventor
Masood A. Chowhan
Huagang Chen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33539082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2116227(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI2116227T1 publication Critical patent/SI2116227T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200432047T 2003-06-13 2004-06-08 Oftalmični sestavki, ki vsebujejeo sinergistično kombinacijo dveh polimerov SI2116227T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47825303P 2003-06-13 2003-06-13
EP09168920.8A EP2116227B1 (en) 2003-06-13 2004-06-08 Ophthalmic compositions containing a synergistic combination of two polymers

Publications (1)

Publication Number Publication Date
SI2116227T1 true SI2116227T1 (sl) 2013-07-31

Family

ID=33539082

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200432047T SI2116227T1 (sl) 2003-06-13 2004-06-08 Oftalmični sestavki, ki vsebujejeo sinergistično kombinacijo dveh polimerov

Country Status (16)

Country Link
US (1) US7709012B2 (sl)
EP (5) EP2116227B1 (sl)
JP (4) JP4860475B2 (sl)
KR (5) KR101131056B1 (sl)
CN (1) CN100475192C (sl)
AU (2) AU2004249137B2 (sl)
BR (1) BRPI0411361B1 (sl)
CA (6) CA2839847C (sl)
DK (1) DK2116227T3 (sl)
ES (3) ES2410505T3 (sl)
MX (1) MXPA05013290A (sl)
PL (1) PL2116227T3 (sl)
PT (1) PT2116227E (sl)
SI (1) SI2116227T1 (sl)
WO (1) WO2004112836A2 (sl)
ZA (1) ZA200509440B (sl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7759296B2 (en) * 2003-06-19 2010-07-20 Lubrizol Advanced Materials, Inc. Cationic polymers and fixative application therefor
KR20120005052A (ko) * 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
EP2070518A2 (en) * 2006-07-25 2009-06-17 Osmotica Corp. Ophthalmic solutions
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
PL2109442T3 (pl) * 2007-02-09 2014-07-31 Novartis Ag Kompozycje oftalmiczne zawierające synergistyczną kombinację trzech polimerów
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
CN101784287B (zh) 2007-06-26 2013-04-24 若素制药株式会社 水性组合物
KR101529093B1 (ko) 2007-08-29 2015-06-16 와카모토 세이야꾸 가부시끼가이샤 라타노프로스트 함유 수성 의약 조성물
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
CN101977630B (zh) * 2008-03-07 2012-11-21 太阳医药高级研发有限公司 眼药组合物
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2011018800A2 (en) * 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
CA2833591A1 (en) * 2011-04-22 2012-10-26 Alcon Research, Ltd. Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
TWI652072B (zh) * 2011-12-07 2019-03-01 歐樂根公司 使用鹽敏感性乳液系統對人類淚液膜進行高效脂質傳遞
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
EP3470059B1 (en) 2015-01-26 2020-04-01 Bausch & Lomb Incorporated Ophthalmic suspension composition
EP3310363A4 (en) * 2015-06-18 2019-02-13 Common Pharma, Inc ANTIMICROBIAL FORMULATIONS
JP6132968B1 (ja) * 2016-01-29 2017-05-24 参天製薬株式会社 ドルゾラミド、高分子およびホウ酸を含有する医薬組成物
TWI743107B (zh) 2016-04-22 2021-10-21 日商樂敦製藥股份有限公司 容器與眼科組成物之組合
EP3446682B1 (en) * 2016-04-22 2021-05-26 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
US9867810B1 (en) 2016-08-19 2018-01-16 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
TWI833913B (zh) * 2019-02-27 2024-03-01 日商參天製藥股份有限公司 含有迪夸弗索(diquafosol)或其鹽、乙烯系高分子及纖維素系高分子之眼科用組合物
WO2024180453A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Dissolvable polymeric eye inserts with a non-ionic cellulose derivative
WO2024180472A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355336A (en) 1966-08-18 1967-11-28 Du Pont Thickened water-bearing inorganic oxidizer salt explosive containing crosslinked galactomannan and polyacrylamide
NL188266C (nl) 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4039662A (en) 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
DE3440352A1 (de) * 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
FR2601385B1 (fr) * 1986-07-09 1989-09-29 Sucre Rech & Dev Procede de preparation a partir de saccharose d'un melange de sucres a haute teneur en isomaltose par voie enzymatique et produits obtenus
US4783488A (en) * 1987-01-31 1988-11-08 Bausch & Lomb Incorporated Contact lens wetting solution
US4767463A (en) 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5368843A (en) 1988-06-08 1994-11-29 Lever Brothers Company, Division Of Conopco, Inc. Thickening system
US5204325A (en) * 1988-12-15 1993-04-20 Lindstrom Richard L Viscoelastic solution
US5075104A (en) 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
WO1992017174A1 (en) * 1991-03-27 1992-10-15 Senju Pharmaceutical Co., Ltd. Process for preparing aqueous suspension
JP2808378B2 (ja) * 1991-03-27 1998-10-08 武田薬品工業株式会社 水性懸濁液剤の製造法
US5460834A (en) 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
JP2787131B2 (ja) * 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
CN1085106A (zh) * 1993-10-27 1994-04-13 吴亮 眼科手术用带有荧光的粘弹性物质
CA2134376C (en) * 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
ES2116681T3 (es) 1994-03-18 1998-07-16 Senju Pharma Co Preparaciones oftalmicas para reducir la presion intraocular.
SE9401108D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
US5939485A (en) 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
WO1998043643A1 (fr) * 1997-04-01 1998-10-08 Toa Medicine Co., Ltd. Preparations d'une solution aqueuse d'acyclovir
JP3361106B2 (ja) 1997-07-29 2003-01-07 アルコン ラボラトリーズ，インコーポレイテッド ハードコンタクトレンズ・ケアのためのコンディショニング溶液
PT999825E (pt) 1997-07-29 2004-02-27 Alcon Lab Inc Composicoes oftalmicas contendo polimeros de galactomanano e borato
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
DE69923987T2 (de) * 1998-10-08 2006-11-02 Karagoezian, Hampar L., San Juan Capistrano Synergistische antimikrobielle, dermatologische und ophtahalmologische zubereitung, die ein chlorit und wasserstoffperoxid enthalten
US6174859B1 (en) * 1999-04-06 2001-01-16 J & D Sciences, Inc. Method of treatment
US7084130B2 (en) * 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
ES2339745T3 (es) * 2000-12-20 2010-05-25 Alcon, Inc. Solucion de irrigacion intraocular que tiene caracteristicas de fluidez mejoradas.
AR035509A1 (es) 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
JP3455852B2 (ja) * 2000-12-26 2003-10-14 株式会社オフテクス 洗眼液組成物
WO2002060495A1 (en) * 2001-01-09 2002-08-08 Louis Johan Wagenaar Procedure and composition of treatment and/or care of the eye
JP2003137775A (ja) * 2001-10-31 2003-05-14 Menicon Co Ltd 眼科用組成物
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
JP2003183157A (ja) * 2001-12-19 2003-07-03 Lion Corp 眼科用組成物
US20040118414A1 (en) 2002-12-20 2004-06-24 Shah Mandar V Surface modified viscoelastics for ocular surgery
WO2003059391A2 (en) 2001-12-21 2003-07-24 Alcon, Inc. Viscoelastics for ocular surgery
US7128928B2 (en) 2002-02-22 2006-10-31 Pharmacia Corporation Ophthalmic formulation with novel gum composition
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
EP1624858B1 (en) 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Novel encochleation methods
US20040241151A1 (en) 2003-05-27 2004-12-02 Sca Hygiene Products Ab Polymer matrix with lactic acid producing bacteria
JP4694773B2 (ja) * 2003-06-06 2011-06-08 ロート製薬株式会社 粘膜適用液状組成物
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
TWM258789U (en) * 2004-06-09 2005-03-11 Ming-Hsiang Yeh Interactive toy
US20060003964A1 (en) 2004-06-30 2006-01-05 Shah Mandar V Dilution resistant viscoelastic compositions
PL2109442T3 (pl) 2007-02-09 2014-07-31 Novartis Ag Kompozycje oftalmiczne zawierające synergistyczną kombinację trzech polimerów

Also Published As

Publication number Publication date
CA2839849C (en) 2017-03-07
EP2116227A3 (en) 2009-12-30
ES2570856T3 (es) 2016-05-20
BRPI0411361A (pt) 2006-07-25
EP3028692B1 (en) 2020-04-22
KR20110032007A (ko) 2011-03-29
EP2526929B1 (en) 2016-04-06
JP2011026354A (ja) 2011-02-10
ES2415738T3 (es) 2013-07-26
KR101147046B1 (ko) 2012-05-22
CA2839898A1 (en) 2004-12-29
JP2011184463A (ja) 2011-09-22
KR101131056B1 (ko) 2012-04-23
KR20060012024A (ko) 2006-02-06
EP3028692A1 (en) 2016-06-08
AU2010200297B2 (en) 2012-04-26
DK2116227T3 (da) 2013-05-27
CA2839847C (en) 2016-03-15
CA2839930A1 (en) 2004-12-29
EP2526929A8 (en) 2013-04-10
AU2010200297A1 (en) 2010-02-18
CA2839847A1 (en) 2004-12-29
KR20110098863A (ko) 2011-09-01
CA2839928A1 (en) 2004-12-29
KR20120062846A (ko) 2012-06-14
EP2526929A1 (en) 2012-11-28
CA2839898C (en) 2017-01-24
ZA200509440B (en) 2007-04-25
CA2839930C (en) 2016-07-05
CA2527712A1 (en) 2004-12-29
KR20110134525A (ko) 2011-12-14
PT2116227E (pt) 2013-06-28
PL2116227T3 (pl) 2013-08-30
WO2004112836A8 (en) 2013-02-14
CN100475192C (zh) 2009-04-08
EP2361610A1 (en) 2011-08-31
MXPA05013290A (es) 2006-03-09
AU2004249137B2 (en) 2010-03-11
CA2839849A1 (en) 2004-12-29
JP4860475B2 (ja) 2012-01-25
EP2116227A2 (en) 2009-11-11
JP2007500244A (ja) 2007-01-11
JP2013100360A (ja) 2013-05-23
EP2361610B1 (en) 2013-04-24
AU2004249137A1 (en) 2004-12-29
ES2410505T3 (es) 2013-07-02
CN1802147A (zh) 2006-07-12
US20040253280A1 (en) 2004-12-16
US7709012B2 (en) 2010-05-04
CA2839928C (en) 2016-10-04
CA2527712C (en) 2014-08-05
EP1631257A2 (en) 2006-03-08
WO2004112836A2 (en) 2004-12-29
WO2004112836A3 (en) 2005-06-16
BRPI0411361B1 (pt) 2017-05-23
EP2116227B1 (en) 2013-04-24

Similar Documents

Publication Publication Date Title
PL2116227T3 (pl) Kompozycje oftalmiczne zawierające synergistyczną kombinację dwóch polimerów
PL1633324T3 (pl) Kompozycje oczne zawierające połączenie trzech polimerów mających działanie synergistyczne
EP1603543A4 (en) THERAPEUTIC COMPOSITIONS
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
ZA200605080B (en) Pharmaceutical compositions
HK1089088A1 (en) Skin protecting compositions
GB0300531D0 (en) Pharmaceutical compositions
EP1608385A4 (en) THERAPEUTIC COMPOSITIONS
EG24403A (en) Ophthalmic composition
EP1648411A4 (en) PHARMACEUTICAL COMPOSITIONS
IL171942A0 (en) Compositions containing ecteinascidin-743
GB0329907D0 (en) Compositions
GB0229258D0 (en) Medicinal compositions
EP1613352A4 (en) MICRO-AGREED COMPOSITIONS
EP1661573A4 (en) OPHTHALMIC COMPOSITION
GB0329597D0 (en) Compositions
EP1655029A4 (en) MEDICINAL COMPOSITIONS
EP1647273A4 (en) OPHTHALMIC COMPOSITION
GB0300602D0 (en) Compositions
SI1633324T1 (sl) Oftalmicni sestavki, ki vsebujejo sinergisticno kombinacijo treh polimerov
GB0324574D0 (en) Novel compositions
GB0305579D0 (en) Pharmaceutical compositions
GB0316857D0 (en) Compositions
GB0517918D0 (en) Elastomeric compositions